251 related articles for article (PubMed ID: 6442563)
21. Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP).
Adami S; Guarrera G; Salvagno G; Spiazzi G; Marini G; Rosini S; Lo Cascio V
Metab Bone Dis Relat Res; 1984; 5(6):265-7. PubMed ID: 6238218
[TBL] [Abstract][Full Text] [Related]
22. Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
Cantrill JA; Buckler HM; Anderson DC
Ann Rheum Dis; 1986 Dec; 45(12):1012-8. PubMed ID: 3813665
[TBL] [Abstract][Full Text] [Related]
23. Calcitonin and diphosphonate in the treatment of Paget's disease of bone.
Hosking DJ
Metab Bone Dis Relat Res; 1981; 3(4-5):317-26. PubMed ID: 6820113
[TBL] [Abstract][Full Text] [Related]
24. APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
Bijvoet OL; Frijlink WB; Jie K; van der Linden H; Meijer CJ; Mulder H; van Paassen HC; Reitsma PH; te Velde J; de Vries E; van der Wey JP
Arthritis Rheum; 1980 Oct; 23(10):1193-204. PubMed ID: 6448605
[No Abstract] [Full Text] [Related]
25. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of resistant Paget's disease of bone with pamidronate.
Mallette LE
Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study].
Eisinger J; Laponche AM; Ouaniche J
Rev Rhum Mal Osteoartic; 1986 Mar; 53(3):183-5. PubMed ID: 3085204
[No Abstract] [Full Text] [Related]
28. Treatment of Paget's disease of bone.
Evans RA
Med J Aust; 1983 Feb; 1(4):159-62. PubMed ID: 6405139
[TBL] [Abstract][Full Text] [Related]
29. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
Nuti R; Turchetti V; Righi G; Vattimo A
Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
[TBL] [Abstract][Full Text] [Related]
30. A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
Chakravarty K; Merry P; Scott DG
J Rheumatol; 1994 Nov; 21(11):2118-21. PubMed ID: 7869320
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
32. Effects of intravenous pamidronate therapy on Paget's disease of bone.
Bombassei GJ; Yocono M; Raisz LG
Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
[TBL] [Abstract][Full Text] [Related]
33. Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonate.
Rico H; Hernández ER; Younes M; Hernández D; Espinós D
Bone; 1988; 9(1):63-6. PubMed ID: 3132191
[TBL] [Abstract][Full Text] [Related]
34. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
Schweiz Med Wochenschr; 1989 Jan; 119(3):71-4. PubMed ID: 2711157
[TBL] [Abstract][Full Text] [Related]
35. Procollagen-III peptide serum levels in Paget's disease of the bone.
Wilder-Smith CH; Raue F; Holz-Gottswinter G; Ziegler R
Klin Wochenschr; 1987 Feb; 65(4):174-8. PubMed ID: 3104661
[TBL] [Abstract][Full Text] [Related]
36. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
[TBL] [Abstract][Full Text] [Related]
37. Paget's disease of bone: five regimens of pamidronate treatment.
Pepersack T; Karmali R; Gillet C; François D; Fuss M
Clin Rheumatol; 1994 Mar; 13(1):39-44. PubMed ID: 8187442
[TBL] [Abstract][Full Text] [Related]
38. Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
Vega E; Mautalen C; Roldán EJ; Pérez Lloret A
Drugs Exp Clin Res; 1994; 20(3):103-8. PubMed ID: 7956716
[TBL] [Abstract][Full Text] [Related]
39. Long-term therapy of Paget's disease of bone with EHDP.
Siris ES; Canfield RE; Jacobs TP; Baquiran DC
Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
[TBL] [Abstract][Full Text] [Related]
40. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
